Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma

Patients who have no residual invasive cancer following neoadjuvant chemotherapy for breast carcinoma have a better overall survival than those with residual disease. Many classification systems assessing pathological response to neoadjuvant chemotherapy include residual ductal carcinoma in situ (DC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jones, R L, Lakhani, S R, Ring, A E, Ashley, S, Walsh, G, Smith, I E
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2006
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361141/
https://ncbi.nlm.nih.gov/pubmed/16421590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602950
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares